YFY Inc. logo

YFY Inc.

Asia, T'ai-pei, Taiwan, Taipei

Description

YFY Inc. is a privately owned paper manufacturers in Taiwan.

Investor Profile

YFY Inc. has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (33%)
  • Series Unknown (33%)
  • Series B (33%)

Country Focus

  • Taiwan (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Hardware
  • Logistics
  • Rfid
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does YFY Inc. frequently co-invest with?

China Development Industrial Bank (CDIB)
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Cathay Life Insurance
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 2
China Steel
Asia, T'ai-wan, Taiwan, Kaohsiung
Co-Investments: 1
Topmark Partners
North America, Florida, United States, Tampa
Co-Investments: 1
Taiwan Sugar Corporation
Asia, T'ai-wan, Taiwan, Tainan
Co-Investments: 1
YFY Biotech Management Company
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
GE Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Trillium Group
North America, New York, United States, Pittsford
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by YFY Inc.?

Omni-ID

Rochester, New York, United States

Omni-ID is engaged in developing passive ultra-high radio frequency identification technology-related products.

HardwareLogisticsRFID
Series UnknownJan 19, 2016
Amount Raised: $21,000,000
TaiGen Biotechnology

Taipei, T'ai-pei, Taiwan

TaiGen is a pharmaceutical company discovering, developing and commercializing drugs to treat cancers, infectious diseases and diabetics.

BiotechnologyHealth CarePharmaceutical
Series CJan 1, 2009
Amount Raised: $37,000,000
TaiGen Biotechnology

Taipei, T'ai-pei, Taiwan

TaiGen is a pharmaceutical company discovering, developing and commercializing drugs to treat cancers, infectious diseases and diabetics.

BiotechnologyHealth CarePharmaceutical
Series BMar 16, 2004
Amount Raised: $38,000,000